Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use LIPFENDRA safely and effectively. See full prescribing information for LIPFENDRA. LIPFENDRA® (enlicitide) tablets, for oral useInitial U.S. Approval: 2026
Medication labelWhy this: Advisory · dailymed-prescription
LIPFENDRA® is indicated as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C) in adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia (HeFH). Cardiovascular outcomes trials have demonstrated that reducing LDL-C lowers the risk for major adverse cardiovascular events (MACE) in adults at increased risk when treated with statins or monoclonal antibody proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors as an add-on to statin therapy.
- generic_name
- lipfendra
- product_names
- LIPFENDRA
- ndc
- 0006-5084, 0006-5084-01, 0006-5084-58, 0006-5084-59
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en